Director Scientific Affairs
Celerion, United Kingdom
Aernout van Haarst, PhD, is a subject matter expert in Celerion’s respiratory research team and supports early phase drug development programs across all indications, including clinical pharmacology studies such as drug-drug-interaction studies. Aernout joined Celerion in 2015 and has over 25 years of drug development experience at biotechnology companies and CROs. He received his PhD from the School of Medicine at Leiden University and is qualified as a Clinical Pharmacologist in The Netherlands.